LCI699

Pipeline

Status by Indication[3][1]

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Hypertension2 trials

A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension

Completed·Novartis·Phase 2·NCT00817414·63 enrolled

A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension

Completed·Novartis·Phase 2·NCT00817635·155 enrolled

Hyperaldosteronism1 trial

Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism

Completed·Novartis·Phase 2·NCT00732771·12 enrolled

Cushing's Syndrome1 trial

Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome

Recruiting·RRECORDATI GROUP·Phase 2·NCT03708900·12 enrolled

Safety and Efficacy1 trial

Safety and Efficacy of LCI699 in Cushing's Disease Patients

Completed·Novartis·Phase 2·NCT01331239·31 enrolled

Essential Hypertension1 trial

A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension

Completed·Novartis·Phase 2·NCT00758524·628 enrolled

Details

Drug Info

Related News